11
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Immune modulation by complement receptor 3-dependent human monocyte TGF-β1-transporting vesicles

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Extracellular vesicles have an important function in cellular communication. Here, we show that human and mouse monocytes release TGF-β1-transporting vesicles in response to the pathogenic fungus Candida albicans. Soluble β-glucan from C. albicans binds to complement receptor 3 (CR3, also known as CD11b/CD18) on monocytes and induces the release of TGF-β1-transporting vesicles. CR3-dependence is demonstrated using CR3-deficient (CD11b knockout) monocytes generated by CRISPR-CAS9 genome editing and isolated from CR3-deficient (CD11b knockout) mice. These vesicles reduce the pro-inflammatory response in human M1-macrophages as well as in whole blood. Binding of the vesicle-transported TGF-β1 to the TGF-β receptor inhibits IL1B transcription via the SMAD7 pathway in whole blood and induces TGFB1 transcription in endothelial cells, which is resolved upon TGF-β1 inhibition. Notably, human complement-opsonized apoptotic bodies induce production of similar TGF-β1-transporting vesicles in monocytes, suggesting that the early immune response might be suppressed through this CR3-dependent anti-inflammatory vesicle pathway.

          Abstract

          Extracellular vesicles can carry immunoregulatory cytokines such as TGF-β. Here the authors use CD11b-deficient mice and macrophages to show that such vesicles carrying TGF-β are produced in response to Candida albicans infections and can limit the proinflammatory response partly via a positive feedback on TGF-β production by endothelial cells.

          Related collections

          Most cited references48

          • Record: found
          • Abstract: found
          • Article: not found

          Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease.

          Transforming growth factor-beta 1 (TGF-beta 1) is a multifunctional growth factor that has profound regulatory effects on many developmental and physiological processes. Disruption of the TGF-beta 1 gene by homologous recombination in murine embryonic stem cells enables mice to be generated that carry the disrupted allele. Animals homozygous for the mutated TGF-beta 1 allele show no gross developmental abnormalities, but about 20 days after birth they succumb to a wasting syndrome accompanied by a multifocal, mixed inflammatory cell response and tissue necrosis, leading to organ failure and death. TGF-beta 1-deficient mice may be valuable models for human immune and inflammatory disorders, including autoimmune diseases, transplant rejection and graft versus host reactions.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression.

            Transforming growth factor beta (TGF-beta) plays an important role in tumor initiation and progression, functioning as both a suppressor and a promoter. The mechanisms underlying this dual role of TGF-beta remain unclear. TGF-beta exerts systemic immune suppression and inhibits host immunosurveillance. Neutralizing TGF-beta enhances CD8+ T-cell- and NK-cell-mediated anti-tumor immune responses. It also increases neutrophil-attracting chemokines resulting in recruitment and activation of neutrophils with an antitumor phenotype. In addition to its systemic effects, TGF-beta regulates infiltration of inflammatory/immune cells and cancer-associated fibroblasts in the tumor microenvironment causing direct changes in tumor cells. Understanding TGF-beta regulation at the interface of tumor and host immunity should provide insights into developing effective TGF-beta antagonists and biomarkers for patient selection and efficacy of TGF-beta antagonist treatment. Published by Elsevier Ltd.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Diverse Roles of TGF-β/Smads in Renal Fibrosis and Inflammation

              TGF-β1 has been long considered as a key mediator in renal fibrosis and induces renal scarring largely by activating its downstream Smad signaling pathway. Interestingly, while mice overexpressing active TGF-β1 develop progressive renal injury, latent TGF-β1 plays a protective role in renal fibrosis and inflammation. Under disease conditions, Smad2 and Smad3 are highly activated, while Smad7 is degraded through the ubiquitin proteasome degradation mechanism. In addition to TGF-β1, many pathogenic mediators such as angiotensin II and advanced glycation end products can also activate the Smad pathway via both TGF-β-dependent and independent mechanisms. Smads interact with other signaling pathways, such as the MAPK and NF-κB pathways, to positively or negatively regulate renal inflammation and fibrosis. Studies from gene knockout mice demonstrate that TGF-β1 acts by stimulating its downstream Smads to diversely regulate kidney injury. In the context of renal fibrosis and inflammation, Smad3 is pathogenic, while Smad2 and Smad7 are protective. Smad4 exerts its diverse roles by transcriptionally enhancing Smad3-mediated renal fibrosis while inhibiting NF-κB-driven renal inflammation via a Smad7-dependent mechanism. Furthermore, we also demonstrated that TGF-β1 acts by stimulating Smad3 to positively or negatively regulate microRNAs to exert its fibrotic role in kidney disease. In conclusion, TGF-β/Smad signaling is a major pathway leading to kidney disease. Smad3 is a key mediator in renal fibrosis and inflammation, whereas Smad2 and Smad7 are renoprotective. Smad4 exerts its diverse role in promoting renal fibrosis while inhibiting inflammation. Thus, targeting the downstream TGF-β/Smad3 signaling pathway by gene transfer of either Smad7 or Smad3-dependent microRNAs may represent a specific and effective therapeutic strategy for kidney disease.
                Bookmark

                Author and article information

                Contributors
                christine.skerka@hki-jena.de
                Journal
                Nat Commun
                Nat Commun
                Nature Communications
                Nature Publishing Group UK (London )
                2041-1723
                11 May 2020
                11 May 2020
                2020
                : 11
                : 2331
                Affiliations
                [1 ]ISNI 0000 0001 0143 807X, GRID grid.418398.f, Department of Infection Biology, Leibniz Institute for Natural Product Research and Infection Biology, ; 07745 Jena, Germany
                [2 ]ISNI 0000 0001 1939 2794, GRID grid.9613.d, Department of Cell Biology, Institute of Biochemistry and Biophysics, Friedrich Schiller University, ; 07745 Jena, Germany
                [3 ]ISNI 0000 0001 0143 807X, GRID grid.418398.f, Department of Molecular and Applied Microbiology, Leibniz Institute for Natural Product Research and Infection Biology, ; 07745 Jena, Germany
                [4 ]ISNI 0000 0000 8517 6224, GRID grid.275559.9, Electron Microscopy Center, University Hospital Jena, ; 07743 Jena, Germany
                [5 ]ISNI 0000 0000 8853 2677, GRID grid.5361.1, Division of Hygiene and Medical Microbiology, Medical University of Innsbruck, ; A-6020 Innsbruck, Austria
                [6 ]ISNI 0000 0001 1958 8658, GRID grid.8379.5, Institute for Virology and Immunobiology, University of Würzburg, ; 97070 Würzburg, Germany
                [7 ]ISNI 0000 0001 0143 807X, GRID grid.418398.f, Research Group Microbial Immunology, Leibniz Institute for Natural Product Research and Infection Biology, ; 07745 Jena, Germany
                [8 ]ISNI 0000 0001 1939 2794, GRID grid.9613.d, Friedrich Schiller University, ; 07743 Jena, Germany
                Author information
                http://orcid.org/0000-0001-5637-5993
                http://orcid.org/0000-0002-6033-9984
                http://orcid.org/0000-0002-6149-2411
                http://orcid.org/0000-0003-2374-6473
                Article
                16241
                10.1038/s41467-020-16241-5
                7214408
                32393780
                4ca23a8d-0abd-41b1-a141-973107a394f3
                © The Author(s) 2020

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 21 May 2019
                : 22 April 2020
                Funding
                Funded by: FundRef https://doi.org/10.13039/501100001659, Deutsche Forschungsgemeinschaft (German Research Foundation);
                Award ID: SFB Transregion 124/2 Funginet C4
                Award ID: SFB Transregio 124/2 Funginet C4
                Award ID: SFB Transregio 124/2 funginet Z2
                Award ID: SFB Transregio 124/2 Funginet C4
                Award ID: SFB Transregio 124/2 Funginet C5
                Award ID: SFB transregio 124/2 C4
                Award ID: SFB Transregio 124/2 Funginet C6
                Award ID: SFB Transregio 124/2 C4
                Award Recipient :
                Categories
                Article
                Custom metadata
                © The Author(s) 2020

                Uncategorized
                monocytes and macrophages,innate immunity,fungal immune evasion
                Uncategorized
                monocytes and macrophages, innate immunity, fungal immune evasion

                Comments

                Comment on this article